cas 1796920-70-1|| where to buy 2-[1-(1,3-benzoxazol-2-yl)pyrrolidine-2-carbonyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline

Product Name:2-[1-(1,3-benzoxazol-2-yl)pyrrolidine-2-carbonyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline

IUPAC Name:2-[1-(1,3-benzoxazol-2-yl)pyrrolidine-2-carbonyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline

Packing Unit	Available Stock	Price($)	Quantity

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1796920-70-1 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:1796920-70-1; Molecular Formula:C23H25N3O4; Melting Point:-; Smiles Code:COC1=CC2=C(CN(CC2)C(=O)C2CCCN2C2=NC3=C(O2)C=CC=C3)C=C1OC; Density:

: Catalog Number:CM833816; Molecular Weight:407.47; Boiling Point:; MDL No:; Storage:

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

: Benzoxazoles; Benzoxazole is an aromatic organic compound with a molecular formula of C7H5NO, a benzoxazole ring structure, and an odor similar to pyridine. Although benzoxazole itself has little practical value, many benzoxazole derivatives are commercially important. As heterocyclic compounds, benzoxazoles are used in research as starting materials for the synthesis of larger, often biologically active structures. Its aromaticity makes it relatively stable, although as a heterocycle it has an active site that enables it to be functionalized.

: Tetrahydroisoquinolines; Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.